Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Dundee Corp T.DC.PR.D


Primary Symbol: T.DC.A Alternate Symbol(s):  DNDPF | DDEJF | T.DC.PR.B | DNDEF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate Corporation. Corporate and Other Portfolio Holdings segment invests in public and private equity and debt securities in diversified industry segments. Goodman & Company, Investment Counsel Inc. includes the activities of Dundee Global Investment Management Inc. Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. United Hydrocarbon International Corp., an 84%-owned private subsidiary engaged in oil and gas exploration through the holding of a royalty interest in the Republic of Chad.


TSX:DC.A - Post by User

Comment by pierrelebelon Jul 01, 2024 9:51pm
45 Views
Post# 36113776

RE:TauRx submits UK marketing authorisation application

RE:TauRx submits UK marketing authorisation application
Taking a look at Genting, owner of 20%+ of TauRx, their shares are basically unchanged in Malaysia.

From discussion boards in Asia, folks seem unimpressed:

"UK MHRA's final decision on CA is unlikely to be within 2024. We still have to file in more submissions which will take abt 5 to 6 months to complete it, followed by another 6 to 9 months for the regulator's final decision.


FDA delayed our Type C meeting request (supposed to be end Jan, before Taurx AGM on 6 Feb @6pm). We are not even sure if FDA will agree to consider HMTM using the Accelerated Approval pathway. If yes, I think FDA's final decision for AA will probably be at least 1.5yrs away."

",,,, once Taurx is approved by UK authorities, Indian factories will start to copy the drug and begin mass production by trillions of kg. Those industries who use legal and illegal Indian workers will start bringing in illegal drug copies for "self consumption"  Malaysian and Global Markets will be flooded with Taurx copies."


<< Previous
Bullboard Posts
Next >>